Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome?

J Thromb Haemost · 2021 · PMC8360052 · PMID 33774918

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Non‐crosslinked mAb IV.3 showed a trend toward inhibiting 28F4‐ and 3B1‐induced platelet aggregation (Figure 3 and not shown).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.